Delivery Order SPE2DB20D1047-SPE2DB24FF79U
Award Date
7/17/24
Potential Completion Date
7/18/24
Potential Value
$103K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $4,066.74, is for the supply of 4,566,035,600 units of the GARDASIL 9 vaccine syringe (0.5 mL) to support federal healthcare programs. The contract has an ultimate completion date of October 8, 2024, and is a firm-fixed-price, non-set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,123.92 firm-fixed-price contract is for the delivery of 4565430340 units of the GARDASIL 9 vaccine syringe (0.5 ML). The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical for providing a comprehensive range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The $3,233.58 firm-fixed-price delivery order is for the supply of 4,565,699 units of the GARDASIL 9 vaccine syringe (0.5mL) with no set-aside designation. The contract has an ultimate completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,242.38, is for the delivery of 4,568,116,064 units of the GARDASIL 9 vaccine syringe (0.5 mL). The contract has an ultimate completion date of May 5, 2025 and was awarded on May 2, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a $8,427.25 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of 4,565,296,692 units of the GARDASIL 9 vaccine syringe (0.5mL) to support federal healthcare programs. The contract has an ultimate completion date of July 31, 2024 and was awarded on July 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds multiple Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a $32,103.85 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,218,430 units of the GARDASIL 9 vaccine syringe (0.5 mL). This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025. The contract has no set-aside designation and is for the delivery of critical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The award, valued at $6,017.19, is for the delivery of 4,565,361,369 units of the GARDASIL 9 vaccine syringe (0.5 mL) to support military treatment programs and facilities. The contract is a Delivery Order with a Firm Fixed Price pricing type. The Ultimate Completion Date is August 7, 2024. Amerisourcebergen, a major...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,896.96 firm fixed-price contract is for the delivery of 4,567,944,220 units of the GARDASIL 9 vaccine syringe (0.5 mL). The contract has an ultimate completion date of April 17, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
This delivery order contract, valued at $8,569.49, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has a completion date of September 23, 2024 and is structured as a firm fixed price arrangement. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 syringes. The contract has a ceiling value of $7,054.48 and a completion date of June 10, 2024. It is a firm-fixed-price contract and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide the vaccine syringes to support military treatment facilities and other government healthcare programs. This contract is...